Arrowhead Pharmaceuticals Inc. buy B. Riley
Start price
20.07.23
/
50%
€31.22
Target price
20.07.24
€49.32
Performance (%)
-17.26%
End price
21.07.24
€25.83
Summary
This prediction ended on 21.07.24 with a price of €25.83. The prediction for Arrowhead Pharmaceuticals Inc. disappointed with a performance of -17.26%. B__Riley has a follow-up prediction for Arrowhead Pharmaceuticals Inc. where he still thinks Arrowhead Pharmaceuticals Inc. is a Buy. B__Riley has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Arrowhead Pharmaceuticals Inc. | -3.149% | -3.149% | -28.187% |
iShares Core DAX® | -1.114% | 5.062% | 24.922% |
iShares Nasdaq 100 | 1.816% | 9.828% | 29.548% |
iShares Nikkei 225® | 2.113% | 8.218% | 22.231% |
iShares S&P 500 | 2.038% | 7.448% | 30.358% |
Comments by B__Riley for this prediction
In the thread Arrowhead Pharmaceuticals Inc. diskutieren
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) had its "buy" rating re-affirmed by analysts at B. Riley. They now have a $55.00 price target on the stock.
Ratings data for ARWR provided by MarketBeat
In the thread Trading Arrowhead Pharmaceuticals Inc.
Die von B__Riley gewählte maximale Laufzeit wurde überschritten
Current prediction by B__Riley for Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€21.28
12.08.24
12.08.24
€50.31
12.08.25
12.08.25
-19.88%
16:47
16:47